Insider Shareholders with Direct Ownership of Cyclacel Pharmaceuticals, Inc. (CYCC)
This section provides a comprehensive overview of the insiders with direct ownership of Cyclacel Pharmaceuticals, Inc. (CYCC). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Cyclacel Pharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Spiro George Rombotis
President and CEO |
67,670 | 0 | 68,658 $21,970 | 3 |
Dec 21, 2023
Added 8.12%
|
|
Kenneth M. Ferguson
Director |
48,952 | 0 | 44,952 $14,384 | 2 |
Jun 30, 2023
Added 32.07%
|
|
Karin L Walker
Director |
40,602 | 0 | 40,602 $12,992 | 3 |
Jun 30, 2023
Added 34.32%
|
|
Sam L Barker
Director |
40,415 | 12 | 40,415 $12,932 | 5 |
Jun 30, 2023
Added 34.43%
|
|
Christopher S Henney
Director |
39,415 | 0 | 39,415 $12,612 | 3 |
Jun 30, 2023
Added 35.0%
|
|
Robert J. Spiegel
Director |
39,415 | 0 | 39,415 $12,612 | 3 |
Jun 30, 2023
Added 35.0%
|
|
Paul Mc Barron
Director |
33,086 | 0 | 33,378 $10,680 | 2 |
Dec 21, 2023
Added 5.35%
|
|
Mark Kirschbaum
Chief Medical Officer |
31,200 | 0 | 31,200 $9,984 | 1 |
Jan 31, 2023
Added 50.0%
|
|
Lloyd Sems
Director |
18,196 | 0 | 18,196 $5,822 | 2 |
Jun 14, 2022
Added 46.51%
|
|
Brian Schwartz
Interim Chief Medical Officer |
53,102 | 0 | 15,205 $4,865 | 4 |
Jan 29, 2024
Added 45.12%
|
|
Gregory T. Hradsky
Director |
2,374 | 0 | 2,374 $759 | 1 |
Jun 15, 2021
Added 50.0%
|